Nutex Health (NUTX)

• Market cap: $204M
• 1 day: 1.02%
• 5 days: 11.98%
• 1 month: 63.11%
• 3 months: 77.52%
• 6 months: 452.65%
• Year to date: 25.27%
• 1 year: 22.81%
• 5 years: -99.37%
• 10 years: -99.37%
• Sector: Industrials
• Industry: Business Services

About: Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.

Employees: 800

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

522% more capital invested

Capital invested by funds: $1.61M [Q2] → $10M (+$8.41M) [Q3]

3.43% more ownership

Funds ownership: 5.67% [Q2] → 9.09% (+3.43%) [Q3]

0% more funds holding

Funds holding: 28 [Q2] → 28 (+0) [Q3]

0% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 12

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 16

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $45 20% upside
• Avg. target: $52 37% upside
• High target: $60 60% upside

3 analyst ratings

• positive: 3 100%
• neutral: 0 0%
• negative: 0 0%

Maxim Group Anthony Vendetti 64% 1-year accuracy 7 / 11 met price target	33% upside $50	Buy Maintained	12 Nov 2024
Benchmark Bill Sutherland 72% 1-year accuracy 26 / 36 met price target	60% upside $60	Buy Maintained	12 Nov 2024
Maxim Group Anthony Vendetti 64% 1-year accuracy 7 / 11 met price target	20% upside $45	Buy Initiated	18 Sept 2024